Insulet Corporation Receivables Turnover Ratio (PODD), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Insulet Corporation  (NASDAQ: PODD)
 

Insulet Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Insulet Corporation's ability to collect accounts receivable sequentially worsen to 6.93, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Insulet's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 53 days, from 48 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 128 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 454 to 1172.

What is Receivable Turnover Ratio?
What is Insulet Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PODD Receivables Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Receivable Change 92.41 % 104.71 % 17.12 % 23.05 % 20.93 %
Y / Y Revenue Change 33.87 % 31.16 % 29.86 % 32.88 % 28.82 %
Receivable Turnover Ratio (TTM) 6.93 7.67 8.78 8.55 8.41
PODD's Total Ranking # 1172 # 454 # 813 # 1307 # 938
Accounts Receivable average collection period days 53 48 42 43 43
Seq. Receivable Change 5.38 % 68.65 % 0.03 % 8.23 % 12.12 %
Seq. Revenue Change -2.81 % 10.96 % 8.81 % 14.08 % -4.77 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 41
Healthcare Sector # 129
Overall Market # 1172

Receivable Turnover Ratio Statistics
High Average Low
11.32 7.73 -4.49
(Sep 30 2017)   (Dec 31 2018)




  News about Insulet Corporation Receivables Turnover Ratios

Insulet Expands Reach with Launch of Omnipod 5 in Europe Amid Financial Challenges

In a significant advancement for diabetes management, Insulet Corporation, a pioneer in tubeless insulin pump technology headquartered in Acton, Massachusetts, has announced the commercial launch of its revolutionary Omnipod 5 Automated Insulin Delivery System in five additional countries across Europe: Italy, Denmark, Finland, Norway, and Sweden. This move marks another step in Insulet s mission to provide innovative diabetes care solutions to patients globally.The Omnipod 5 system, designed to simplify insulin delivery, enhances patient convenience and lifestyle integration. Notably, the new system is compatible with both Abbott s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensors, allowing users to maintain more precise control over their blood glucose levels. This compatibility is expected to facilitate better management of diabetes for users in the newly added European markets, thereby improving their quality of life.


PODD Company Profile • Back to PODD Efficiency Comparisons • Compare PODD Receivables Turnover Ratio to its Competitors

Financial Statements
Insulet's Accounts Receivable $ 545 Millions Visit PODD's Balance sheet
Insulet's Sales TTM $ 2,901 Millions Visit PODD's Income Statement
Sources of PODD's Revenues Visit PODD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PODD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PODD's Growth Rates PODD's Roa PODD's Inventory Turnover Ratio PODD's Dividend Comparisons
PODD's Profitability Ratios PODD's Roi PODD's Asset Turnover Ratio PODD's Dividend Growth
PODD's Valuation Ratios PODD's Roe PODD's Financial Strength Ratios PODD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions
Talkspace Inc   13.67 $ 239.269  Millions$ 17.501  Millions
Marpai Inc  13.59 $ 17.125  Millions$ 1.261  Millions
Amneal Pharmaceuticals Inc   13.56 $ 3,045.530  Millions$ 224.634  Millions
Corcept Therapeutics Inc  13.20 $ 769.096  Millions$ 58.264  Millions
Rosecliff Acquisition Corp I  13.19 $ 20.547  Millions$ 1.557  Millions
Xoma Royalty Corporation  13.05 $ 48.555  Millions$ 3.720  Millions
Mannkind Corporation  13.00 $ 360.783  Millions$ 27.757  Millions
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions
Precision Biosciences Inc  11.94 $ 45.073  Millions$ 3.776  Millions
Teladoc Health Inc   11.94 $ 2,514.453  Millions$ 210.660  Millions
Option Care Health Inc   11.65 $ 5,666.577  Millions$ 486.439  Millions
Ensysce Biosciences Inc   11.55 $ 4.708  Millions$ 0.407  Millions
Crinetics Pharmaceuticals Inc   11.52 $ 18.069  Millions$ 1.569  Millions
Icu Medical Inc  11.46 $ 2,156.379  Millions$ 188.157  Millions
Nrc Health  11.42 $ 138.642  Millions$ 12.138  Millions
Nuvation Bio Inc   11.41 $ 142.121  Millions$ 12.454  Millions
Integrated Biopharma Inc  11.34 $ 47.241  Millions$ 4.165  Millions
National Healthcare Corp  11.07 $ 1,525.905  Millions$ 137.813  Millions
Vireo Growth Inc.  11.01 $ 350.469  Millions$ 31.834  Millions
Bioaffinity Technologies Inc   10.79 $ 5.660  Millions$ 0.525  Millions

Date modified: 2026-08-29T17:16:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.